Core/shell Printing Scaffolds For Tissue Engineering Of Tubular Structures
September 27th, 2019
10.1K views
Presented here is a simple-to-use, core/shell, three-dimensional bioprinting set-up for one-step fabrication of hollow scaffolds, suitable for tissue engineering of vascular and other tubular structures.
Overview
This article presents a core/shell, three-dimensional bioprinting setup for the one-step fabrication of hollow scaffolds. These scaffolds are suitable for tissue engineering applications, particularly for vascular and tubular structures.
Key Study Components
Area of Science
- Tissue Engineering
- 3D Bioprinting
- Scaffold Fabrication
Background
- The development of tubular structures is critical for creating vascular networks in thick tissues.
- Core/shell bioprinting allows for efficient production of hollow scaffolds.
- Proper hydrogel formulation and flow management are essential for successful 3D printing.
- Direct printing with cells can enhance scaffold functionality.
Purpose of Study
- To demonstrate a simplified method for fabricating hollow scaffolds.
- To explore the potential for direct cell incorporation during the printing process.
- To provide a detailed protocol for scaffold preparation and cell seeding.
Methods Used
- Preparation of hydrogel and crosslinking solutions.
- Assembly of a core/shell nozzle for 3D printing.
- Printing of scaffolds followed by secondary crosslinking.
- Cell culture and seeding within the printed scaffolds.
Main Results
- Successfully printed hollow scaffolds with a stable structure.
- Demonstrated effective cell incorporation and viability within the scaffolds.
- Maintained hollow channels throughout the scaffold length after incubation.
- Live/dead assays confirmed the health of endothelial cells in the scaffolds.
Conclusions
- The core/shell bioprinting technique enables efficient scaffold fabrication.
- Direct printing with cells can enhance the functionality of the scaffolds.
- This method holds promise for advancing tissue engineering applications.
Frequently Asked Questions
What is the core/shell bioprinting technique?
It is a method for creating hollow scaffolds in a single step, allowing for efficient tissue engineering.
How are cells incorporated into the scaffolds?
Cells are injected into the hollow channels of the printed scaffolds after fabrication.
What types of structures can be fabricated using this method?
Hollow scaffolds suitable for vascular and tubular structures can be created.
What are the advantages of this bioprinting setup?
It simplifies the fabrication process and reduces time while allowing for direct cell printing.
How is scaffold stability ensured during printing?
By using a hydrogel with appropriate viscoelastic properties and managing material flow.
What is the significance of the live/dead assay?
It assesses the viability of cells within the scaffolds after culture.
Executive Industry Relevance
This core/shell bioprinting method enables one-step fabrication of hollow tubular scaffolds, addressing a critical bottleneck in vascular tissue engineering by reducing production complexity and time. The approach supports predictive confidence in scaffold design through reproducible hollow channel formation and compatibility with cell seeding workflows. It positions the technique as a translatable platform for de-risking early-stage vascular construct development in preclinical pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of vascular network formation hypotheses through precise hollow scaffold fabrication.
- Operational Value: Reduces iterative prototyping by providing a stable, reproducible tubular structure in a single print step.
Screening & Assay Development
- Scientific Value: Produces standardized hollow channels compatible with live/dead and fluorescence-based viability assays.
- Operational Value: Facilitates consistent cell seeding and medium perfusion for scalable screening of endothelial cell behavior.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant modeling of tubular structures by maintaining perfusable lumens over extended culture periods.
- Operational Value: Enables seamless transition from scaffold fabrication to cell incorporation and long-term incubation without structural compromise.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by enabling early-stage vascular scaffold production that informs lead identification and preclinical validation through structural and functional readouts.
- Discovery Biology: Supports hypothesis testing of angiogenic pathways via controlled tubular microenvironment fabrication.
- Screening: Delivers assay-ready scaffolds with quantifiable hollow channel integrity for compound or cell performance evaluation.
- Analytics: Provides measurable outputs such as channel patency and cell viability for comparative condition analysis.
- Translational Research: Maintains structural and functional continuity from discovery to preclinical validation through stable lumen retention.
- Enterprise Reuse: Represents a modular nozzle system adaptable across biomaterials and cell types for platform-level standardization.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in vascular construct design by eliminating multi-step fabrication artifacts.
- Operational Value: Improves reproducibility and throughput through Luer-compatible, sterile-ready nozzle assembly.
- Strategic Value: Reduces biological de-risking timelines by enabling rapid iteration of tubular scaffold designs.
- Portfolio Impact: Supports go/no-go decisions in vascular tissue engineering programs via early-stage structural validation.
Implementation Considerations
- Requires expertise in hydrogel rheology and crosslinking kinetics for stable core/shell printing.
- Dependent on dual-extrusion 3D printer compatibility and sterile fluid handling systems.
- Necessitates standardization of flow rates and nozzle alignment across teams for batch consistency.
- Adaptation to alternative biomaterials may require recalibration of core/shell viscosity balance.
- Limited by nozzle inner diameter resolution, which constrains minimum achievable channel size.
Biopharma FAQs
Why does hollow channel formation matter for target validation?
Hollow channel formation enables precise recreation of vascular lumen geometry, which is essential for validating angiogenic targets and perfusion-dependent pathways in tubular tissue models.
How does independent variable isolation fit the discovery pipeline?
Isolating variables like crosslinking timing and core flow rate allows researchers to attribute structural outcomes to specific material or process inputs, supporting mechanistic de-risking in early discovery.
What quantitative dependent variable measurements enable assay readiness?
Measurements such as channel diameter consistency, lumen retention over time, and endothelial cell viability provide quantifiable benchmarks for scaffold performance in screening applications.
Why do replication requirements matter for cross-functional collaboration?
Reproducible hollow scaffold fabrication ensures that biology, engineering, and screening teams can rely on consistent structural outputs, reducing variability in multi-disciplinary vascular model evaluations.
What statistical analysis capabilities are required before implementation?
Basic comparative analysis of channel integrity and cell seeding efficiency across print batches is needed to establish process reliability and support data-driven go/no-go decisions in scaffold development.
